Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market. Detailed analysis of key players, along with key growth strategies adopted by Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Astellas
Janssen Pharmaceuticals
Kotobuki Pharmaceutical
Eli Lilly
Bristol Myers Squibb
AstraZeneca
Boehringer Ingelheim
By Type:
Invokana (Canagliflozin)
Jardiance (Empagliflozin)
Farxiga/Forxiga (Dapagliflozin)
Suglat (Ipragliflozin)
By End-User:
Hospital
Medical Research Institute
Other
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market
-
1.3 Market Segment by Type
-
1.3.1 USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Invokana (Canagliflozin) from 2016 to 2027
-
1.3.2 USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Jardiance (Empagliflozin) from 2016 to 2027
-
1.3.3 USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Farxiga/Forxiga (Dapagliflozin) from 2016 to 2027
-
1.3.4 USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Suglat (Ipragliflozin) from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.2 USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Medical Research Institute from 2016 to 2027
-
1.4.3 USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Major Types
-
3.4.1 Market Size and Growth Rate of Invokana (Canagliflozin)
-
3.4.2 Market Size and Growth Rate of Jardiance (Empagliflozin)
-
3.4.3 Market Size and Growth Rate of Farxiga/Forxiga (Dapagliflozin)
-
3.4.4 Market Size and Growth Rate of Suglat (Ipragliflozin)
4 Segmentation of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Major End-Users
-
4.4.1 Market Size and Growth Rate of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors in Hospital
-
4.4.2 Market Size and Growth Rate of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors in Medical Research Institute
-
4.4.3 Market Size and Growth Rate of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors in Other
5 Market Analysis by Regions
-
5.1 USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Analysis by Regions
-
5.2 USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis
-
6.1 West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis by Major Types
-
6.2 West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis by Major End-Users
7 South USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis
-
7.1 South USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis by Major Types
-
7.2 South USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis by Major End-Users
8 Middle West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis
-
8.1 Middle West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis by Major Types
-
8.2 Middle West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis by Major End-Users
9 Northeast USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis
-
9.1 Northeast USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis by Major Types
-
9.2 Northeast USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Astellas
-
10.1.1 Astellas Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Janssen Pharmaceuticals
-
10.2.1 Janssen Pharmaceuticals Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Kotobuki Pharmaceutical
-
10.3.1 Kotobuki Pharmaceutical Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Eli Lilly
-
10.4.1 Eli Lilly Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Bristol Myers Squibb
-
10.5.1 Bristol Myers Squibb Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 AstraZeneca
-
10.6.1 AstraZeneca Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Boehringer Ingelheim
-
10.7.1 Boehringer Ingelheim Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Invokana (Canagliflozin) from 2016 to 2027
-
Figure USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Jardiance (Empagliflozin) from 2016 to 2027
-
Figure USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Farxiga/Forxiga (Dapagliflozin) from 2016 to 2027
-
Figure USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Suglat (Ipragliflozin) from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Medical Research Institute from 2016 to 2027
-
Figure USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Different Types from 2016 to 2027
-
Table Consumption Share of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Invokana (Canagliflozin)
-
Figure Market Size and Growth Rate of Jardiance (Empagliflozin)
-
Figure Market Size and Growth Rate of Farxiga/Forxiga (Dapagliflozin)
-
Figure Market Size and Growth Rate of Suglat (Ipragliflozin)
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Different End-Users from 2016 to 2027
-
Table Consumption Share of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Medical Research Institute
-
Figure Market Size and Growth Rate of Other
-
Table USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production by Regions
-
Table USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Share by Regions
-
Figure USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Share by Regions in 2016
-
Figure USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Share by Regions in 2021
-
Figure USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Share by Regions in 2027
-
Table USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption by Regions
-
Table USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Regions
-
Figure USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Regions in 2016
-
Figure USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Regions in 2021
-
Figure USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Regions in 2027
-
Table West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption by Types from 2016 to 2027
-
Table West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types from 2016 to 2027
-
Figure West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types in 2016
-
Figure West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types in 2021
-
Figure West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types in 2027
-
Table West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption by End-Users from 2016 to 2027
-
Table West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users in 2016
-
Figure West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users in 2021
-
Figure West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users in 2027
-
Table South USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption by Types from 2016 to 2027
-
Table South USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types from 2016 to 2027
-
Figure South USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types in 2016
-
Figure South USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types in 2021
-
Figure South USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types in 2027
-
Table South USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption by End-Users from 2016 to 2027
-
Table South USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users in 2016
-
Figure South USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users in 2021
-
Figure South USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users in 2027
-
Table Middle West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption by Types from 2016 to 2027
-
Table Middle West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types in 2016
-
Figure Middle West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types in 2021
-
Figure Middle West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types in 2027
-
Table Middle West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users in 2016
-
Figure Middle West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users in 2021
-
Figure Middle West USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users in 2027
-
Table Northeast USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption by Types from 2016 to 2027
-
Table Northeast USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types in 2016
-
Figure Northeast USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types in 2021
-
Figure Northeast USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types in 2027
-
Table Northeast USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users in 2016
-
Figure Northeast USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users in 2021
-
Figure Northeast USA Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Astellas
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas
-
Figure Sales and Growth Rate Analysis of Astellas
-
Figure Revenue and Market Share Analysis of Astellas
-
Table Product and Service Introduction of Astellas
-
Table Company Profile and Development Status of Janssen Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Janssen Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Janssen Pharmaceuticals
-
Table Product and Service Introduction of Janssen Pharmaceuticals
-
Table Company Profile and Development Status of Kotobuki Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kotobuki Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Kotobuki Pharmaceutical
-
Figure Revenue and Market Share Analysis of Kotobuki Pharmaceutical
-
Table Product and Service Introduction of Kotobuki Pharmaceutical
-
Table Company Profile and Development Status of Eli Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
-
Figure Sales and Growth Rate Analysis of Eli Lilly
-
Figure Revenue and Market Share Analysis of Eli Lilly
-
Table Product and Service Introduction of Eli Lilly
-
Table Company Profile and Development Status of Bristol Myers Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol Myers Squibb
-
Figure Sales and Growth Rate Analysis of Bristol Myers Squibb
-
Figure Revenue and Market Share Analysis of Bristol Myers Squibb
-
Table Product and Service Introduction of Bristol Myers Squibb
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Boehringer Ingelheim
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim
-
Figure Sales and Growth Rate Analysis of Boehringer Ingelheim
-
Figure Revenue and Market Share Analysis of Boehringer Ingelheim
-
Table Product and Service Introduction of Boehringer Ingelheim
-
